HomeGYRE • NASDAQ
add
Gyre Therapeutics Inc
Previous close
$11.19
Day range
$11.01 - $11.63
Year range
$8.26 - $26.36
Market cap
1.06B USD
Avg Volume
123.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 25.49M | -20.45% |
Operating expense | 20.30M | 12.18% |
Net income | 1.12M | -71.73% |
Net profit margin | 4.41 | -64.46% |
Earnings per share | — | — |
EBITDA | 4.69M | -63.85% |
Effective tax rate | 27.33% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.09M | 13.20% |
Total assets | 125.24M | — |
Total liabilities | 26.77M | — |
Total equity | 98.47M | — |
Shares outstanding | 85.82M | — |
Price to book | 15.12 | — |
Return on assets | 8.60% | — |
Return on capital | 10.82% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 1.12M | -71.73% |
Cash from operations | 1.73M | -77.24% |
Cash from investing | -2.39M | 55.80% |
Cash from financing | 324.00K | — |
Net change in cash | -231.00K | -109.82% |
Free cash flow | 449.62K | — |
About
Founded
2002
Headquarters
Website
Employees
593
